| 1,3-dinitrobenzene | increases expression | ISO | RGD:620545 | 6480464 | 3-dinitrobenzene results in increased expression of CHEK1 mRNA | CTD | PMID:22841810 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:732293 | 6480464 | Ethinyl Estradiol affects the expression of CHEK1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:732293 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CHEK1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:732293 | 6480464 | Ethinyl Estradiol results in increased expression of CHEK1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CHEK1 mRNA | CTD | PMID:16474171 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CHEK1 mRNA | CTD | PMID:16474171 PMID:19167446 |
| 17beta-estradiol | affects expression | ISO | RGD:732293 | 6480464 | Estradiol affects the expression of CHEK1 mRNA | CTD | PMID:15598610 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of CHEK1 mRNA | CTD | PMID:19318562 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases phosphorylation | EXP | | 6480464 | Metribolone results in increased phosphorylation of CHEK1 protein | CTD | PMID:23272087 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732293 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CHEK1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732293 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CHEK1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHEK1 mRNA | CTD | PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732293 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CHEK1 mRNA | CTD | PMID:15667827 PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732293 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CHEK1 mRNA | CTD | PMID:19465110 PMID:15667827 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | RGD:732293 | 6480464 | Butylated Hydroxytoluene results in increased expression of CHEK1 mRNA | CTD | PMID:19000923 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CHEK1 mRNA | CTD | PMID:21179406 |
| 3,3',5-triiodo-L-thyronine | increases phosphorylation | EXP | | 6480464 | Triiodothyronine analog results in increased phosphorylation of CHEK1 protein | CTD | PMID:22383522 |
| 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:732293 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CHEK1 mRNA | CTD | PMID:20188158 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:732293 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CHEK1 mRNA | CTD | PMID:19191707 |
| 5-aza-2'-deoxycytidine | affects localization | EXP | | 6480464 | decitabine affects the localization of CHEK1 protein modified form | CTD | PMID:17991895 |
| 5-fluoro-2'-deoxyuridine | multiple interactions | EXP | | 6480464 | Floxuridine results in increased phosphorylation of and results in increased activity of CHEK1 protein | CTD | PMID:21613406 PMID:22194930 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CHEK1 protein affects the susceptibility to Fluorouracil | CTD | PMID:18698031 |
| 5-fluorouracil | decreases expression | ISO | RGD:732293 | 6480464 | Fluorouracil results in decreased expression of CHEK1 mRNA | CTD | PMID:19272435 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | Fluorouracil results in increased phosphorylation of and results in increased activity of CHEK1 protein | CTD | PMID:21613406 PMID:22194930 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein inhibits the reaction [Fluorouracil results in increased expression of CHEK1 protein]; more ... | CTD | PMID:15016801 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of CHEK1 protein | CTD | PMID:15016801 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | [CHEK1 protein co-treated with TP53 protein] affects the susceptibility to Fluorouracil; more ... | CTD | PMID:18698031 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:732293 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| acrylamide | increases expression | ISO | RGD:732293 | 6480464 | Acrylamide results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of CHEK1 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CHEK1 mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | increases expression | ISO | RGD:732293 | 6480464 | Tretinoin results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| ammonium chloride | affects expression | ISO | RGD:620545 | 6480464 | Ammonium Chloride affects the expression of CHEK1 mRNA | CTD | PMID:16483693 |
| ammonium chloride | decreases expression | ISO | RGD:620545 | 6480464 | Ammonium Chloride results in decreased expression of CHEK1 protein | CTD | PMID:16483693 |
| anthracene-1,8,9-triol | increases expression | ISO | RGD:732293 | 6480464 | Anthralin results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| aphidicolin | multiple interactions | ISO | RGD:732293 | 6480464 | [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein]; more ... | CTD | PMID:22003191 |
| benzo[a]pyrene | increases phosphorylation | EXP | | 6480464 | Benzo(a)pyrene results in increased phosphorylation of CHEK1 protein | CTD | PMID:20542099 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | cobaltous chloride promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of CHEK1 protein] | CTD | PMID:20228066 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | CLSPN mRNA affects the reaction [Benzo(a)pyrene results in increased phosphorylation of CHEK1 protein] | CTD | PMID:19464357 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CHEK1 mRNA | CTD | PMID:21802500 |
| benzo[a]pyrene | increases phosphorylation | EXP | | 6480464 | Benzo(a)pyrene results in increased phosphorylation of CHEK1 protein | CTD | PMID:19464357 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:620545 | 6480464 | Benzo(a)pyrene results in increased expression of CHEK1 protein modified form | CTD | PMID:21604763 |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Mustard Gas results in increased phosphorylation of CHEK1 protein]; more ... | CTD | PMID:22119920 |
| bis(2-chloroethyl) sulfide | increases phosphorylation | EXP | | 6480464 | Mustard Gas results in increased phosphorylation of CHEK1 protein | CTD | PMID:22119920 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CHEK1 mRNA | CTD | PMID:16474171 |
| busulfan | multiple interactions | EXP | | 6480464 | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK1 protein | CTD | PMID:20933509 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein] | CTD | PMID:19261750 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; more ... | CTD | PMID:15975956 |
| caffeine | decreases expression | ISO | RGD:732293 | 6480464 | Caffeine results in decreased expression of CHEK1 protein modified form | CTD | PMID:21505179 |
| caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of CHEK1 protein | CTD | PMID:21561856 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Hydroxyurea promotes the reaction [ATR protein results in increased phosphorylation of and results in increased activity of CHEK1 protein]] | CTD | PMID:18158334 |
| carmustine | multiple interactions | EXP | | 6480464 | ATR protein affects the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein]; more ... | CTD | PMID:19261750 |
| catechol | increases expression | ISO | RGD:732293 | 6480464 | catechol results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| cefaloridine | increases expression | ISO | RGD:620545 | 6480464 | Cephaloridine results in increased expression of CHEK1 mRNA | CTD | PMID:18500788 |
| chlorpyrifos | decreases expression | ISO | RGD:732293 | 6480464 | Chlorpyrifos results in decreased expression of CHEK1 mRNA | CTD | PMID:20350560 |
| cholic acid | increases expression | ISO | RGD:732293 | 6480464 | Cholic Acid results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| choline | affects expression | EXP | | 6480464 | Choline affects the expression of CHEK1 mRNA | CTD | PMID:17616785 |
| choline | multiple interactions | ISO | RGD:732293 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CHEK1 mRNA | CTD | PMID:20938992 |
| ciprofloxacin | increases expression | ISO | RGD:620545 | 6480464 | Ciprofloxacin results in increased expression of CHEK1 protein | CTD | PMID:18512786 |
| cisplatin | multiple interactions | EXP | | 6480464 | BRCA1 mutant form promotes the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased activity of and results in increased phosphorylation of CHEK1 protein]]]; more ... | CTD | PMID:21875941 |
| cisplatin | multiple interactions | ISO | RGD:732293 | 6480464 | [7-hydroxystaurosporine results in decreased activity of [CHEK1 protein co-treated with BSCL2 protein]] inhibits the reaction [Cisplatin results in increased expression of CHEK2 mRNA]; more ... | CTD | PMID:22003191 |
| cisplatin | multiple interactions | EXP | | 6480464 | ESR2 protein inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:20623183 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of CHEK1 protein | CTD | PMID:20623183 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin results in increased phosphorylation of and results in increased activity of CHEK1 protein | CTD | PMID:21107699 PMID:21875941 |
| cisplatin | increases phosphorylation | ISO | RGD:732293 | 6480464 | Cisplatin results in increased phosphorylation of CHEK1 protein | CTD | PMID:21285353 PMID:22006019 |
| cisplatin | increases activity | EXP | | 6480464 | Cisplatin results in increased activity of CHEK1 protein | CTD | PMID:21592546 PMID:21324906 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of CHEK1 protein | CTD | PMID:21285353 PMID:21356574 |
| cisplatin | increases phosphorylation | ISO | RGD:732293 | 6480464 | Cisplatin results in increased phosphorylation of CHEK1 protein | CTD | PMID:22006019 PMID:21285353 |
| cisplatin | multiple interactions | ISO | RGD:732293 | 6480464 | PRKDC protein mutant form promotes the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:21324906 |
| cisplatin | multiple interactions | EXP | | 6480464 | ERCC6 protein inhibits the reaction [Cisplatin results in increased activity of CHEK1 protein] | CTD | PMID:21324906 |
| cisplatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:21356574 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of CHEK1 protein | CTD | PMID:21356574 PMID:21285353 |
| cisplatin | increases activity | EXP | | 6480464 | Cisplatin results in increased activity of CHEK1 protein | CTD | PMID:21324906 PMID:21592546 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CHEK1 protein | CTD | PMID:12740909 |
| clofarabine | multiple interactions | EXP | | 6480464 | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK1 protein | CTD | PMID:20933509 |
| clofibrate | increases expression | ISO | RGD:732293 | 6480464 | Clofibrate results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CHEK1 mRNA | CTD | PMID:19376846 PMID:19320972 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CHEK1 mRNA | CTD | PMID:19320972 PMID:19376846 |
| cobalt dichloride | increases phosphorylation | EXP | | 6480464 | cobaltous chloride results in increased phosphorylation of CHEK1 protein | CTD | PMID:20228066 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | cobaltous chloride promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of CHEK1 protein] | CTD | PMID:20228066 |
| copper atom | increases expression | ISO | RGD:620545 | 6480464 | Copper results in increased expression of CHEK1 mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CHEK1 mRNA | CTD | PMID:20971185 |
| copper(0) | increases expression | ISO | RGD:620545 | 6480464 | Copper results in increased expression of CHEK1 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CHEK1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CHEK1 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of CHEK1 mRNA | CTD | PMID:19167446 |
| curcumin | decreases response to substance | EXP | | 6480464 | CHEK1 protein results in decreased susceptibility to Curcumin | CTD | PMID:18602917 |
| curcumin | increases activity | EXP | | 6480464 | Curcumin results in increased activity of CHEK1 protein | CTD | PMID:18602917 |
| curcumin | increases phosphorylation | EXP | | 6480464 | Curcumin results in increased phosphorylation of CHEK1 protein | CTD | PMID:19401701 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CHEK1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CHEK1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| diarsenic trioxide | increases phosphorylation | ISO | RGD:732293 | 6480464 | arsenic trioxide results in increased phosphorylation of CHEK1 protein | CTD | PMID:16891316 |
| diarsenic trioxide | increases phosphorylation | EXP | | 6480464 | arsenic trioxide results in increased phosphorylation of CHEK1 protein | CTD | PMID:16891316 |
| dibutyl phthalate | decreases expression | ISO | RGD:732293 | 6480464 | Dibutyl Phthalate results in decreased expression of CHEK1 mRNA | CTD | PMID:21266533 |
| digitoxin | decreases expression | EXP | | 6480464 | Digitoxin results in decreased expression of CHEK1 protein; more ... | CTD | PMID:22037315 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Doxorubicin results in increased phosphorylation of CHEK1 protein]; more ... | CTD | PMID:17085670 |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CHEK1 protein | CTD | PMID:17085670 more ... |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CHEK1 protein | CTD | PMID:17088865 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:21356574 PMID:17088865 |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CHEK1 protein | CTD | PMID:21356574 more ... |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CHEK1 protein | CTD | PMID:21356574 more ... |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CHEK1 protein | CTD | PMID:17088865 more ... |
| doxorubicin | affects response to substance | EXP | | 6480464 | CHEK1 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 PMID:18698031 |
| doxorubicin | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Doxorubicin] | CTD | PMID:18698031 |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CHEK1 protein | CTD | PMID:17085670 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:17088865 PMID:21356574 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of and results in increased activity of CHEK1 protein | CTD | PMID:17320279 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CHEK1 protein | CTD | PMID:15870702 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CHEK1 mRNA | CTD | PMID:16036217 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [DNMT1 protein binds to CHEK1 protein] | CTD | PMID:17991895 |
| doxorubicin | affects response to substance | EXP | | 6480464 | CHEK1 protein affects the susceptibility to Doxorubicin | CTD | PMID:18698031 PMID:16217747 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK1 protein]] | CTD | PMID:15489221 |
| etoposide | affects response to substance | EXP | | 6480464 | CHEK1 protein affects the susceptibility to Etoposide | CTD | PMID:18698031 |
| etoposide | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Etoposide] | CTD | PMID:18698031 |
| fenofibrate | increases expression | ISO | RGD:620545 | 6480464 | Fenofibrate results in increased expression of CHEK1 mRNA | CTD | PMID:17264098 |
| folic acid | affects expression | EXP | | 6480464 | Folic Acid affects the expression of CHEK1 mRNA | CTD | PMID:16361273 |
| folic acid | multiple interactions | ISO | RGD:732293 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CHEK1 mRNA | CTD | PMID:20938992 |
| furan | increases expression | ISO | RGD:620545 | 6480464 | furan results in increased expression of CHEK1 mRNA | CTD | PMID:20562052 |
| furan | increases expression | ISO | RGD:732293 | 6480464 | furan results in increased expression of CHEK1 mRNA | CTD | PMID:20194422 |
| furan | increases expression | ISO | RGD:620545 | 6480464 | furan results in increased expression of CHEK1 mRNA | CTD | PMID:20562052 PMID:22079235 |
| furosemide | affects expression | ISO | RGD:620545 | 6480464 | Furosemide affects the expression of CHEK1 mRNA | CTD | PMID:17497460 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CHEK1 mRNA | CTD | PMID:16474171 |
| Goe 6976 | decreases activity | EXP | | 6480464 | Go 6976 results in decreased activity of CHEK1 protein | CTD | PMID:20619533 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of CHEK1 mRNA | CTD | PMID:12414654 |
| hydroxyurea | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Hydroxyurea promotes the reaction [ATR protein results in increased phosphorylation of and results in increased activity of CHEK1 protein]] | CTD | PMID:18158334 |
| hydroxyurea | decreases expression | ISO | RGD:732293 | 6480464 | Hydroxyurea results in decreased expression of CHEK1 mRNA | CTD | PMID:12929121 |
| indole-3-methanol | affects expression | ISO | RGD:620545 | 6480464 | indole-3-carbinol affects the expression of CHEK1 mRNA | CTD | PMID:21396975 |
| indole-3-methanol | multiple interactions | ISO | RGD:620545 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK1 mRNA | CTD | PMID:22129741 |
| iron dichloride | increases expression | ISO | RGD:732293 | 6480464 | ferrous chloride results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| iron trichloride | increases expression | ISO | RGD:732293 | 6480464 | ferric chloride results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| isoflurane | decreases expression | ISO | RGD:620545 | 6480464 | Isoflurane results in decreased expression of CHEK1 mRNA | CTD | PMID:16978161 |
| L-methionine | multiple interactions | ISO | RGD:732293 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CHEK1 mRNA | CTD | PMID:20938992 |
| lead diacetate | increases expression | ISO | RGD:732293 | 6480464 | lead acetate results in increased expression of CHEK1 mRNA | CTD | PMID:22609695 |
| leptomycin B | decreases expression | EXP | | 6480464 | leptomycin B results in decreased expression of CHEK1 mRNA | CTD | PMID:20803015 |
| lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:21356574 |
| lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:17088865 PMID:21356574 |
| lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of CHEK1 protein] | CTD | PMID:21356574 PMID:17088865 |
| menadione | decreases expression | EXP | | 6480464 | Vitamin K 3 results in decreased expression of CHEK1 mRNA | CTD | PMID:12414654 |
| methyl isocyanate | increases expression | ISO | RGD:732293 | 6480464 | methyl isocyanate results in increased expression of CHEK1 mRNA | CTD | PMID:22223508 |
| methylmercury chloride | decreases expression | ISO | RGD:732293 | 6480464 | methylmercuric chloride results in decreased expression of CHEK1 mRNA | CTD | PMID:20061341 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK1 protein]] | CTD | PMID:15489221 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:732293 | 6480464 | ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 protein]; more ... | CTD | PMID:19919837 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:620545 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK1 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:732293 | 6480464 | Diethylnitrosamine results in increased expression of CHEK1 mRNA | CTD | PMID:17854601 PMID:19919837 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:732293 | 6480464 | Diethylnitrosamine results in increased expression of CHEK1 protein | CTD | PMID:19919837 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:732293 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CHEK1 mRNA] | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:732293 | 6480464 | Diethylnitrosamine results in increased expression of CHEK1 mRNA | CTD | PMID:19919837 PMID:17854601 |
| ochratoxin A | increases expression | ISO | RGD:620545 | 6480464 | ochratoxin A results in increased expression of CHEK1 mRNA | CTD | PMID:19237604 |
| ozone | increases expression | ISO | RGD:732293 | 6480464 | Ozone results in increased expression of CHEK1 mRNA | CTD | PMID:19555225 |
| paclitaxel | decreases expression | ISO | RGD:732293 | 6480464 | Paclitaxel results in decreased expression of CHEK1 mRNA | CTD | PMID:12929121 |
| paracetamol | increases expression | ISO | RGD:732293 | 6480464 | Acetaminophen results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:732293 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CHEK1 mRNA | CTD | PMID:19000923 |
| pirinixic acid | increases expression | ISO | RGD:732293 | 6480464 | pirinixic acid results in increased expression of CHEK1 mRNA | CTD | PMID:20813756 |
| pirinixic acid | multiple interactions | ISO | RGD:732293 | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of CHEK1 mRNA | CTD | PMID:20813756 |
| platinum | multiple interactions | EXP | | 6480464 | Platinum analog results in increased phosphorylation of and results in increased activity of CHEK1 protein | CTD | PMID:21107699 |
| platinum(0) | multiple interactions | EXP | | 6480464 | Platinum analog results in increased phosphorylation of and results in increased activity of CHEK1 protein | CTD | PMID:21107699 |
| propiconazole | increases expression | ISO | RGD:732293 | 6480464 | propiconazole results in increased expression of CHEK1 mRNA | CTD | PMID:21278054 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CHEK1 mRNA | CTD | PMID:19167446 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CHEK1 mRNA | CTD | PMID:18089832 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CHEK1 protein | CTD | PMID:18089832 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA | CTD | PMID:19167446 |
| resveratrol | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; more ... | CTD | PMID:15975956 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CHEK1 mRNA | CTD | PMID:18191903 |
| saccharin | increases expression | ISO | RGD:732293 | 6480464 | Saccharin results in increased expression of CHEK1 mRNA | CTD | PMID:19000923 |
| silver(1+) nitrate | increases expression | EXP | | 6480464 | Silver Nitrate analog results in increased expression of CHEK1 mRNA | CTD | PMID:22831968 |
| styrene oxide | increases expression | ISO | RGD:732293 | 6480464 | styrene oxide results in increased expression of CHEK1 protein | CTD | PMID:20025956 |
| succimer | multiple interactions | ISO | RGD:732293 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHEK1 mRNA | CTD | PMID:21641980 |
| tamoxifen | affects expression | ISO | RGD:732293 | 6480464 | Tamoxifen affects the expression of CHEK1 mRNA | CTD | PMID:17555576 |
| temozolomide | increases phosphorylation | EXP | | 6480464 | temozolomide results in increased phosphorylation of CHEK1 protein | CTD | PMID:15930307 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of CHEK1 mRNA | CTD | PMID:12414654 |
| thioacetamide | increases expression | ISO | RGD:620545 | 6480464 | Thioacetamide results in increased expression of CHEK1 mRNA | CTD | PMID:22659510 |
| thioacetamide | increases phosphorylation | ISO | RGD:620545 | 6480464 | Thioacetamide results in increased phosphorylation of CHEK1 protein | CTD | PMID:22659510 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CHEK1 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CHEK1 mRNA | CTD | PMID:18089832 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CHEK1 protein | CTD | PMID:18089832 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; more ... | CTD | PMID:15975956 |
| trimellitic anhydride | increases expression | ISO | RGD:732293 | 6480464 | trimellitic anhydride results in increased expression of CHEK1 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CHEK1 mRNA | CTD | PMID:19140230 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CHEK1 mRNA | CTD | PMID:20585447 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein] | CTD | PMID:19261750 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Mustard Gas results in increased phosphorylation of CHEK1 protein] | CTD | PMID:22119920 |
| wortmannin | decreases expression | EXP | | 6480464 | wortmannin results in decreased expression of CHEK1 protein | CTD | PMID:22409540 |
| zidovudine | increases phosphorylation | EXP | | 6480464 | Zidovudine results in increased phosphorylation of CHEK1 protein | CTD | PMID:19541796 |
| zidovudine | decreases expression | EXP | | 6480464 | Zidovudine results in decreased expression of CHEK1 protein | CTD | PMID:19541796 |
| zinc dichloride | increases expression | ISO | RGD:732293 | 6480464 | zinc chloride results in increased expression of CHEK1 mRNA | CTD | PMID:19000923 |